Liquid Biopsies for Solid Tumors
October 6, 2015 | Terry Sharrer
There are nine companies now in development of liquid biopsies for solid tumors, though none have won FDA approval for clinical use so far. This piece reviews the issues in an emerging field, which one authority expects to grow from $100 million today to $20 billion in the next five years. MORE
Image Credit: www.torange.us